Who
Peter Hug
Director
Company insider
Files Form 4 as: Director, ADC Therapeutics SA.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $3,448
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 13 Jun 2024
- Last trade
- 3 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $6,6402,156 at $3.08 | filing |
| 3 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $6,6402,156 at $3.08 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 13 Jun 2025filed 17 Jun 2025 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $7,6762,144 at $3.58 | filing |
| 3 Jun 2025filed 5 Jun 2025 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2024filed 18 Jun 2024 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Sold | $3,4481,193 at $2.89 | filing |
| 13 Jun 2024filed 14 Jun 2024 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
Head to Head Survey: Kymera Therapeutics (NASDAQ:KYMR) versus ADC Therapeutics (NYSE:ADCT)ADCT · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Peter Hug; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.